array:23 [
  "pii" => "S0014256509000228"
  "issn" => "00142565"
  "doi" => "10.1016/j.rce.2009.04.003"
  "estado" => "S300"
  "fechaPublicacion" => "2010-01-01"
  "aid" => "21"
  "copyright" => "Elsevier España, S.L."
  "copyrightAnyo" => "2009"
  "documento" => "simple-article"
  "crossmark" => 0
  "subdocumento" => "dis"
  "cita" => "Rev Clin Esp. 2010;210:23-7"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:2 [
    "total" => 556
    "formatos" => array:2 [
      "HTML" => 221
      "PDF" => 335
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S0014256509000253"
    "issn" => "00142565"
    "doi" => "10.1016/j.rce.2009.04.004"
    "estado" => "S300"
    "fechaPublicacion" => "2010-01-01"
    "aid" => "21.1"
    "copyright" => "Elsevier España, S.L."
    "documento" => "simple-article"
    "crossmark" => 0
    "subdocumento" => "dis"
    "cita" => "Rev Clin Esp. 2010;210:24-5"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 597
      "formatos" => array:2 [
        "HTML" => 368
        "PDF" => 229
      ]
    ]
    "es" => array:7 [
      "idiomaDefecto" => true
      "titulo" => "Añadir glitazonas. Dra. Lourdes Mateos"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "24"
          "paginaFinal" => "25"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256509000253?idApp=WRCEE"
    "url" => "/00142565/0000021000000001/v3_201302081013/S0014256509000253/v3_201302081013/es/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S001425650900023X"
    "issn" => "00142565"
    "doi" => "10.1016/j.rce.2009.09.001"
    "estado" => "S300"
    "fechaPublicacion" => "2010-01-01"
    "aid" => "22"
    "copyright" => "Elsevier España, S.L"
    "documento" => "simple-article"
    "crossmark" => 0
    "subdocumento" => "edi"
    "cita" => "Rev Clin Esp. 2010;210:20-2"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 1232
      "formatos" => array:2 [
        "HTML" => 798
        "PDF" => 434
      ]
    ]
    "es" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
      "titulo" => "Valoraci&#243;n geri&#225;trica integral y recuperaci&#243;n funcional en unidades de media-larga estancia"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "20"
          "paginaFinal" => "22"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Integral geriatric assessment and functional recovery in middle-long stay units"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "A&#46; Fern&#225;ndez Moyano"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "A&#46;"
              "apellidos" => "Fern&#225;ndez Moyano"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S001425650900023X?idApp=WRCEE"
    "url" => "/00142565/0000021000000001/v3_201302081013/S001425650900023X/v3_201302081013/es/main.assets"
  ]
  "es" => array:14 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">ACTUALIZACI&#211;N CL&#205;NICA&#47;CONDUCTA A SEGUIR</span>"
    "titulo" => "Conducta terap&#233;utica en la diabetes tipo 2&#46; Cuanto m&#225;s breve&#44; mejor"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "23"
        "paginaFinal" => "27"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "L&#46; Mateos, J&#46; Herraez Garc&#237;a, J&#46;A&#46; Martin Oterino, A&#46; S&#225;nchez Rodr&#237;guez"
        "autores" => array:4 [
          0 => array:2 [
            "nombre" => "L&#46;"
            "apellidos" => "Mateos"
          ]
          1 => array:2 [
            "nombre" => "J&#46;"
            "apellidos" => "Herraez Garc&#237;a"
          ]
          2 => array:2 [
            "nombre" => "J&#46;A&#46;"
            "apellidos" => "Martin Oterino"
          ]
          3 => array:4 [
            "nombre" => "A&#46;"
            "apellidos" => "S&#225;nchez Rodr&#237;guez"
            "email" => array:1 [
              0 => "asanro&#64;usal&#46;es"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">¿</span>"
                "identificador" => "cor1"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:1 [
            "entidad" => "Servicio de Medicina Interna I&#44; Hospital Universitario de Salamanca&#44; Salamanca&#44; Espa&#241;a"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor1"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspondencia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Therapeutic behavior to follow in the following clinical case&#58; Treatment of type 2 diabetes"
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2009-03-30"
    "fechaAceptado" => "2009-04-27"
    "PalabrasClave" => array:2 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec17967"
          "palabras" => array:3 [
            0 => "Hipertensi&#243;n"
            1 => "Diabetes"
            2 => "Terap&#233;utica"
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec17968"
          "palabras" => array:3 [
            0 => "Hypertensi&#243;n"
            1 => "Diabetes"
            2 => "Therapeutics"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<p class="elsevierStyleSimplePara elsevierViewall">Una mujer de 62 a&#241;os con obesidad&#44; hipertensi&#243;n arterial y diabetes mellitus tipo 2 es remitida a una unidad de riesgo vascular del servicio de medicina interna porque su HbA<span class="elsevierStyleInf">1c</span> est&#225; elevada &#40;8&#44;1&#37;&#41; a pesar de tomar regularmente metformina &#40;850<span class="elsevierStyleHsp" style=""></span>mg&#47;12<span class="elsevierStyleHsp" style=""></span>h&#41; y glipizida &#40;10<span class="elsevierStyleHsp" style=""></span>mg&#47;12<span class="elsevierStyleHsp" style=""></span>h&#41;&#46; Trata de hacer ejercicio cada d&#237;a &#40;caminar 30<span class="elsevierStyleHsp" style=""></span>min&#41; y ha adelgazado &#40;de 5 a 12<span class="elsevierStyleHsp" style=""></span>kg&#41; en varias ocasiones&#44; pero siempre ha vuelto a ganar lo perdido&#46; Adem&#225;s se controla su glucemia en ayunas cada dos semanas y suele tener entre 120 y 160<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&#46; Su hipertensi&#243;n arterial est&#225; siendo tratada con enalapril&#47;hidroclorotiazida y adem&#225;s toma aspirina &#40;100<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#41; y simvastatina &#40;20<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#41;&#46; En su historia familiar se recoge que un hermano falleci&#243; s&#250;bitamente a los 50 a&#241;os&#46; En la exploraci&#243;n f&#237;sica presenta un IMC de 32&#44;4<span class="elsevierStyleHsp" style=""></span>kg&#47;m<span class="elsevierStyleSup">2</span> y no tiene edemas en los miembros inferiores&#46; Su PA es de 154&#47;82<span class="elsevierStyleHsp" style=""></span>mmHg y la creatinina de 0&#44;9<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&#46; No presenta microalbuminuria y su funci&#243;n hep&#225;tica es normal&#46;</p><p class="elsevierStyleSimplePara elsevierViewall">&#191;Qu&#233; tratamiento le parece a Vd&#46; m&#225;s indicado&#63;</p><p class="elsevierStyleSimplePara elsevierViewall">1&#46; A&#241;adir glitazonas&#46;</p><p class="elsevierStyleSimplePara elsevierViewall">2&#46; A&#241;adir incret&#237;n mim&#233;ticos &#40;glucagon like peptide 1 &#91;GLP1&#93;&#47;inhibidores de la dipeptidilpeptidasa 4 &#91;DPP-4&#93;&#41;&#46;</p><p class="elsevierStyleSimplePara elsevierViewall">3&#46; A&#241;adir insulina de acci&#243;n lenta&#46;</p>"
      ]
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<p class="elsevierStyleSimplePara elsevierViewall">A 62-year old woman with obesity&#44; high blood pressure and type 2 diabetes mellitus &#40;DM2&#41; was referred to a Vascular Risk Unit of the Internal Medicine Department due to elevated HbA1C &#40;8&#46;1&#37;&#41; in spite of having taken metformin &#40;850<span class="elsevierStyleHsp" style=""></span>mg&#47;12<span class="elsevierStyleHsp" style=""></span>h&#41; and glipizide &#40;10<span class="elsevierStyleHsp" style=""></span>mg&#47;12<span class="elsevierStyleHsp" style=""></span>h&#41; regularly&#46; She tries to exercise daily &#40;walking 30<span class="elsevierStyleHsp" style=""></span>min&#41; and has lost weight &#40;from 5 to 12<span class="elsevierStyleHsp" style=""></span>kg&#41; several times&#44; but always regains what she has lost&#46; Furthermore&#44; she monitors her glucose levels in fasting every two weeks and generally has between 120 and 160<span class="elsevierStyleHsp" style=""></span>mg&#47;dL&#46; Her high blood pressure is being treated with enalapril&#47;HCTZ and she also takes aspirin 100<span class="elsevierStyleHsp" style=""></span>mg&#47;day and simvastatin 20<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#46; It is seen in her family background that one brother died suddenly at 50 years of age&#46; Her physical examination shows a BMI of 32&#46;4<span class="elsevierStyleHsp" style=""></span>Kg&#47;m<span class="elsevierStyleSup">2</span>&#44; and she has no edemas in the lower limbs&#46; Her BP is 154&#47;82<span class="elsevierStyleHsp" style=""></span>mmHg and creatinine 0&#46;9<span class="elsevierStyleHsp" style=""></span>mg&#47;dL&#46; She has no microalbuminuria and her liver function is normal&#46;</p><p class="elsevierStyleSimplePara elsevierViewall">What treatment do you think would be the more appropriate&#63;</p><p class="elsevierStyleSimplePara elsevierViewall">1 - Add glitazones&#46;</p><p class="elsevierStyleSimplePara elsevierViewall">2 - Add incretin mimetics &#40;GLP 1&#47; DPP-4&#41;&#46;</p><p class="elsevierStyleSimplePara elsevierViewall">3 - Slow acting insulin&#46;</p>"
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/00142565/0000021000000001/v3_201302081013/S0014256509000228/v3_201302081013/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "995"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Actualizaci&#243;n cl&#237;nica"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/00142565/0000021000000001/v3_201302081013/S0014256509000228/v3_201302081013/es/main.pdf?idApp=WRCEE&text.app=https://www.revclinesp.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256509000228?idApp=WRCEE"
]
Share
Journal Information
Vol. 210. Issue 1.
Pages 23-27 (January 2010)
Share
Share
Download PDF
More article options
Vol. 210. Issue 1.
Pages 23-27 (January 2010)
ACTUALIZACIÓN CLÍNICA/CONDUCTA A SEGUIR
Conducta terapéutica en la diabetes tipo 2. Cuanto más breve, mejor
Therapeutic behavior to follow in the following clinical case: Treatment of type 2 diabetes
L. Mateos, J. Herraez García, J.A. Martin Oterino, A. Sánchez Rodríguez
Corresponding author
asanro@usal.es

Autor para correspondencia.
Servicio de Medicina Interna I, Hospital Universitario de Salamanca, Salamanca, España
Article information
Abstract
Download PDF
Statistics
Resumen

Una mujer de 62 años con obesidad, hipertensión arterial y diabetes mellitus tipo 2 es remitida a una unidad de riesgo vascular del servicio de medicina interna porque su HbA1c está elevada (8,1%) a pesar de tomar regularmente metformina (850mg/12h) y glipizida (10mg/12h). Trata de hacer ejercicio cada día (caminar 30min) y ha adelgazado (de 5 a 12kg) en varias ocasiones, pero siempre ha vuelto a ganar lo perdido. Además se controla su glucemia en ayunas cada dos semanas y suele tener entre 120 y 160mg/dl. Su hipertensión arterial está siendo tratada con enalapril/hidroclorotiazida y además toma aspirina (100mg/día) y simvastatina (20mg/día). En su historia familiar se recoge que un hermano falleció súbitamente a los 50 años. En la exploración física presenta un IMC de 32,4kg/m2 y no tiene edemas en los miembros inferiores. Su PA es de 154/82mmHg y la creatinina de 0,9mg/dl. No presenta microalbuminuria y su función hepática es normal.

¿Qué tratamiento le parece a Vd. más indicado?

1. Añadir glitazonas.

2. Añadir incretín miméticos (glucagon like peptide 1 [GLP1]/inhibidores de la dipeptidilpeptidasa 4 [DPP-4]).

3. Añadir insulina de acción lenta.

Palabras clave:
Hipertensión
Diabetes
Terapéutica
Abstract

A 62-year old woman with obesity, high blood pressure and type 2 diabetes mellitus (DM2) was referred to a Vascular Risk Unit of the Internal Medicine Department due to elevated HbA1C (8.1%) in spite of having taken metformin (850mg/12h) and glipizide (10mg/12h) regularly. She tries to exercise daily (walking 30min) and has lost weight (from 5 to 12kg) several times, but always regains what she has lost. Furthermore, she monitors her glucose levels in fasting every two weeks and generally has between 120 and 160mg/dL. Her high blood pressure is being treated with enalapril/HCTZ and she also takes aspirin 100mg/day and simvastatin 20mg/day. It is seen in her family background that one brother died suddenly at 50 years of age. Her physical examination shows a BMI of 32.4Kg/m2, and she has no edemas in the lower limbs. Her BP is 154/82mmHg and creatinine 0.9mg/dL. She has no microalbuminuria and her liver function is normal.

What treatment do you think would be the more appropriate?

1 - Add glitazones.

2 - Add incretin mimetics (GLP 1/ DPP-4).

3 - Slow acting insulin.

Keywords:
Hypertensión
Diabetes
Therapeutics

Article

These are the options to access the full texts of the publication Revista Clínica Española (English Edition)
Member
Si es usted socio de FESEMI siga los siguientes pasos:

Diríjase desde aquí a la web de la >>>FESEMI<<< e inicie sesión mediante el formulario que se encuentra en la barra superior, pulsando sobre el candado.

Una vez autentificado, en la misma web de FESEMI, en el menú superior, elija la opción deseada.

>>>FESEMI<<<

Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Revista Clínica Española (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Email
Idiomas
Revista Clínica Española (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?